相关实验视频
Updated: Jul 23, 2025
08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.4K
阿洛斯特基调节器在喘模型中增强了β2AR激动剂促进的支气管保护
Seungkirl Ahn1, Harm Maarsingh2, Julia Kl Walker1,3
1Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
The Journal of clinical investigation
|July 11, 2023
概括
一种新型化合物,化合物-6 (Cmpd-6),对β-2上腺素受体 (β2ARs) 起积极的异质调节剂 (PAM) 的作用. Cmpd-6增强了β2-激动剂在保护呼吸道方面的有效性,显示出治疗喘和类似呼吸道疾病的前景.
科学领域:
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
- 分子生物学分子生物学
背景情况:
- 喘是一种慢性炎症性呼吸道疾病,其特征是偶发性狭窄.
- 目前吸入的β2上腺素受体 (β2AR) 激动剂在支气管扩张中具有有限的疗效.
- 所有经批准的β2-激动剂都是与上腺素结合到相同部位的 ортостерик配体.
研究的目的:
- 研究一种新型β2AR选择性阳性全调节器 (PAM),化合物-6 (Cmpd-6) 的治疗潜力.
- 在临床前模型和人体组织中评估Cmpd-6对β2AR介导的支气管保护的影响.
主要方法:
- 在海豚,小鼠和人类系统中,Cmpd-6与β2ARs结合的表征.
- 评估Cmpd-6对β2-激动剂诱导的信号和下游效应的影响.
- 在肺部切片中评估Cmpd-6在预防甲胆和过敏原诱导的支气管收缩方面的疗效.
主要成果:
- 在豚鼠和人类的β2ARs中,Cmpd-6全osterically增强β2-agonist结合和信号,但不是小鼠β2ARs.
- 在几内亚猪和人类肺部切片中,cmpd-6增强了β2-激动剂介导的支气管保护,以抵抗甲胆的挑战.
- 该化合物在过敏喘的几内亚猪模型中表现出有效性,改善β2-激动剂的功能.
结论:
- 选择性β2AR PAMs,如Cmpd-6,代表了对喘的有希望的治疗策略.
- 体调节为增强支气管扩张和呼吸道保护提供了一种新的方法.
- 对PAM的进一步研究可能会导致阻塞性呼吸道疾病的治疗方法得到改善.
相关概念视频
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
311
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
311
01:24Antiasthma Drugs: Methylxanthines
272
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
272
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
345
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
345
01:20Asthma: Pathogenesis and Management
450
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
450
01:19Antiasthma Drugs: Leukotriene Modifiers
368
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
368
01:26COPD: Management Using Bronchodilators and Corticosteroids
249
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
249